Cervel Neurotech Scores $11 Million For Device-Based Depression Therapy

Medical maker Cervel Neurotech is nearing the close of an $11.9 million fundraising round in support of its technology-based treatment for mental illness. California-based medical device maker Cervel Neurotech is nearing the close of an $11.9 million funding round, having raised $11.1 million since April 2013 in support of its technology-based therapies for neurological and psychiatric disorders. The company filed an amendment this month citing 8 unnamed investors participating in its financing round, which involved sales of equity, rights and securities.

Help employers find you! Check out all the jobs and post your resume.